Johnson Matthey PLC (LON:JMAT - Get Free Report)'s share price was up 29% during mid-day trading on Thursday . The stock traded as high as GBX 1,888 ($25.34) and last traded at GBX 1,792.32 ($24.06). Approximately 3,427,063 shares were traded during trading, an increase of 25% from the average daily volume of 2,743,881 shares. The stock had previously closed at GBX 1,389 ($18.64).
Johnson Matthey Stock Down 2.4%
The company has a debt-to-equity ratio of 62.73, a current ratio of 1.45 and a quick ratio of 0.76. The company has a market capitalization of £2.96 billion, a PE ratio of 30.10, a P/E/G ratio of 49,242.50 and a beta of 0.95. The business's 50 day simple moving average is GBX 1,302.20 and its 200 day simple moving average is GBX 1,375.09.
Johnson Matthey (LON:JMAT - Get Free Report) last posted its quarterly earnings results on Thursday, May 22nd. The company reported GBX 149.20 ($2.00) earnings per share for the quarter. Johnson Matthey had a net margin of 0.84% and a return on equity of 4.49%. As a group, analysts anticipate that Johnson Matthey PLC will post 173.4112903 earnings per share for the current fiscal year.
Johnson Matthey Increases Dividend
The firm also recently disclosed a dividend, which was paid on Wednesday, April 16th. Investors of record on Thursday, April 10th were given a GBX 32 ($0.43) dividend. This represents a yield of 1.88%. This is a positive change from Johnson Matthey's previous dividend of $22.00. The ex-dividend date was Thursday, April 10th. Johnson Matthey's dividend payout ratio is presently 130.84%.
Insiders Place Their Bets
In related news, insider Liam Condon purchased 30 shares of the company's stock in a transaction on Wednesday, April 16th. The stock was acquired at an average cost of GBX 1,200 ($16.11) per share, for a total transaction of £360 ($483.22). Insiders acquired a total of 75 shares of company stock valued at $99,927 over the last quarter. 0.61% of the stock is owned by insiders.
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
